Patent & Trademark

     Pfizer and Dr. Robert Jarvik insist their use and promotion of Lipitor and Caduet do not violate Dr. Mathew Gelfand’s patent on “use of thrombolytic reagents for prevention of vascular disease,” which patent they say is invalid and unenforceable, in Manhattan Federal Court.




     
     Breaking the Chain Foundation claims Capitol Educational Support violates its “Breaking the Chain” trademark, in DC Federal Court. Both groups say they are trying to eradicate intergenerational incarceration in the Capital Area.

%d bloggers like this: